KAPA
insider transactionsKairos Pharma, LTD. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
19.1K sh
Own +35%
-
Grant·A
Director
$0
19.1K sh
Own +63%
-
Grant·A
Director
$0
19.1K sh
Own +191%
-
Grant·A
Samuelson Doug KEY
Chief Financial Officer
$0
152.7K sh
Own +109%
-
Grant·A
VP of Research and Development
$0
152.7K sh
Own +104%
-
Grant·A
Yu John S KEY
CEO and Chairman
$0
190.8K sh
Own +486%
-
Grant·A
Chief Scientific Officer
$0
171.8K sh
Own +15%
-
Grant·A
Director
$0
10.0K sh
Own +23%
-
Grant·A
Director
$0
10.0K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 8, 2025 | Bae Hyun W. | Grant A | 19.1K | $0 |
| Oct 8, 2025 | Singhvi Rahul | Grant A | 19.1K | $0 |
| Oct 8, 2025 | Keyoung Hansoo Michael | Grant A | 19.1K | $0 |
| Oct 8, 2025 | Samuelson Doug KEY | Grant A | 152.7K | $0 |
| Oct 8, 2025 | Murali Ramachandran | Grant A | 152.7K | $0 |
| Oct 8, 2025 | Yu John S KEY | Grant A | 190.8K | $0 |
| Oct 8, 2025 | Bhowmick Neil | Grant A | 171.8K | $0 |
| Sep 16, 2025 | Bae Hyun W. | Grant A | 10.0K | $0 |
| Sep 16, 2025 | Keyoung Hansoo Michael | Grant A | 10.0K | $0 |
About KAPA insider trading
This page tracks insider transactions for Kairos Pharma, LTD. (KAPA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.